| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9954450 | European Journal of Cancer | 2018 | 17 Pages |
Abstract
ANXA1 acts as a tumour suppressor in HNSCC. It is involved in the regulation of EGFR activity and exosomal phospho-EGFR release and could be an important prognostic biomarker.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
N. Raulf, P. Lucarelli, S. Thavaraj, S. Brown, J.M. Vicencio, T. Sauter, M. Tavassoli,